Research Topics
| S L WoldenSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)Suzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021 6007, USA
Am J Clin Oncol 36:97-101. 2013..This practice guideline can be part of ensuring quality and safety in a successful TBI program...
Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology GroupSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, SM 17, New York, NY 10065, USA
J Clin Oncol 30:3174-80. 2012..We present the long-term study outcome using final data through March 2007...
Management of breast cancer after Hodgkin's diseaseS L Wolden
Departments of Radiation Oncology, Medicine, and Surgery, Stanford University Medical Center, Stanford, CA, USA
J Clin Oncol 18:765-72. 2000..To evaluate the incidence, detection, pathology, management, and prognosis of breast cancer occurring after Hodgkin's disease...
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experienceSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 64:57-62. 2006..We now evaluate whether IMRT has resulted in improved outcomes for a larger cohort of patients with longer follow-up...
Radiation therapy for non-rhabdomyosarcoma soft tissue sarcomas in adolescents and young adultsSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Pediatr Hematol Oncol 27:212-4. 2005..Results of anticipated cooperative group studies promise to guide future therapy for the various types of NRSTS...
Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcomaSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 61:1432-8. 2005..To determine the preliminary results of intensity-modulated radiotherapy (IMRT) for head-and-neck rhabdomyosarcoma...
Sarcomas across the age spectrumSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Semin Radiat Oncol 20:45-51. 2010..The other 2 are synovial sarcoma, which can be looked at as a bridge between pediatric and adult sarcomas as it affects mainly young adults, and liposarcoma that is almost exclusively an adult sarcoma...
Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastomaSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 22, New York, NY 10021, USA
J Clin Oncol 21:3079-83. 2003..To assess the patterns of failure for patients with medulloblastoma receiving a conformal tumor bed boost rather than a boost to the entire posterior fossa...
Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcomaSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, SM07, New York, NY 10021, USA
Cancer 97:179-85. 2003..The authors evaluated the outcome of patients with rhabdomyosarcoma (RMS) who were treated with three-dimensional (3D) conformal radiation therapy (RT) at a single institution...
Brain-sparing radiotherapy for neuroblastoma skull metastasesSuzanne L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Pediatr Blood Cancer 50:1163-8. 2008..The purpose of this study was to describe the technique, outcome and toxicities in patients with high risk NB metastatic to the skull treated with brain-sparing skull radiotherapy (BSRT)...
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancerS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 46:859-64. 2000..33%, p < 0.05) over radiation alone. The 10-year actuarial rate of severe complications was 24%.60 Gy are used for gross disease. The addition of chemotherapy decreases the risk of distant metastases and increases survival...
Local control with multimodality therapy for stage 4 neuroblastomaS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 46:969-74. 2000..To evaluate the efficacy of 21 Gy hyperfractionated radiotherapy for local control in conjunction with surgery and intensive systemic therapy for patients with Stage 4 neuroblastoma...
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinomaS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 19:1105-10. 2001..To evaluate the feasibility and efficacy of concomitant boost radiotherapy (RT) plus cisplatin-based chemotherapy compared with standard fractionation RT for patients with advanced nasopharyngeal cancer...
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinomaS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 49:1229-34. 2001..To determine whether the use of 3-dimensional (3D) boost for patients with nasopharynx cancer improves local control and reduces the risk of long-term complications...
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacyMichelle L Klem
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
Int J Radiat Oncol Biol Phys 70:1100-7. 2008..With conventional techniques, significant toxicity can develop. Intensity-modulated radiotherapy (IMRT) has the potential to minimize the toxicity...
Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experienceBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 67:691-702. 2007..To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center...
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicitiesBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Int J Radiat Oncol Biol Phys 72:763-9. 2008..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
Results of multimodal treatment for desmoplastic small round cell tumorsDave R Lal
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Pediatr Surg 40:251-5. 2005..4 years (range, 0.4-11.2 years). CONCLUSIONS: Multimodal therapy results in improved survival in patients with DSRCT. Aggressive surgical resection of these extensive intraabdominal neoplasms correlates with improved patient outcome...
Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicityBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
Head Neck 30:925-32. 2008....
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinomaWilliam C Chen
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Cancer 106:820-9. 2006..This dose should serve as a Dmean constraint maximum for intensity-modulated radiotherapy treatment of nasopharynx carcinoma...
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern eraTrang H La
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 64:544-50. 2006..The presence of metastases at diagnosis is a predictive factor not only for death but also for local failure...
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastomaVictoria J Croog
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 78:849-54. 2010..This study describes the use of craniospinal irradiation (CSI) for CNS relapse and compares outcomes to patients who received focal radiotherapy (RT)...
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8Kim Kramer
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 25:5465-70. 2007..We tested the toxicity, pharmacokinetics, and dosimetry of intraventricular iodine-131-labeled monoclonal antibody 3F8 (131I-3F8) targeting GD2-positive CNS/LM disease in a phase I clinical trial...
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experienceDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 70:1365-72. 2008..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinomaNancy Y Lee
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 66:966-74. 2006..intensity-modulated radiotherapy (IMRT) in the setting of concurrent chemotherapy (CT) for locally advanced oropharyngeal carcinoma...
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancersNancy Y Lee
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 69:459-68. 2007..To perform a retrospective review of laryngeal/hypopharyngeal carcinomas treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT)...
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experienceStephanie A Terezakis
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 73:795-801. 2009..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancersDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 73:1096-103. 2009..To present our single-institution experience of intensity-modulated radiotherapy (IMRT) for oral cavity cancer...
Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid glandDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer 115:2128-37. 2009..The aim of the current study was to determine patterns of failure and adverse prognostic features...
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigmDavid G Pfister
Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 24:1072-8. 2006..Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy...
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastomaBrian H Kushner
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 75:1181-6. 2009..To present a large experience (73 patients) using a standard radiotherapy (RT) protocol to prevent relapse in cranial sites where measurable metastatic neuroblastoma (NB), an adverse prognostic marker, is common...
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastomaKim Kramer
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 429, New York, NY 10065, USA
J Neurooncol 97:409-18. 2010..The cRIT-salvage regimen for CNS metastases was well tolerated by young patients, despite their prior history of intensive cytotoxic therapies. It has the potential to increase survival with better than expected quality of life...
Radiotherapy after surgical resection for head and neck mucosal melanomaAbraham J Wu
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Am J Clin Oncol 33:281-5. 2010..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck...
Intensive multimodality therapy for patients with stage 4a metastatic retinoblastomaIra J Dunkel
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Pediatr Blood Cancer 55:55-9. 2010....
Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experienceCherry L Estilo
Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Pediatr Hematol Oncol 25:215-22. 2003..To describe potential effects of multimodality therapy on dental and facial development in long-term survivors of head and neck rhabdomyosarcoma...
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancerBenjamin D Rosenbluth
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 63:1419-26. 2005..Ideal planning target volume doses have yet to be determined. Additional patients and long-term follow-up are needed to confirm these preliminary findings and to clarify late toxicities...
Ureteral reconstruction for retroperitoneal tumors in childrenDaniel N Rutigliano
Division of Pediatric Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Pediatr Surg 42:355-8. 2007..Ureteral stricture can also be a result of intense therapy. We present our experience with urinary reconstruction in this situation...
Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experienceKaryn A Goodman
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Brachytherapy 2:139-46. 2003..IOHDR alone may not be appropriate in the majority of patients. Subacute toxicities occurred rarely and may be related to the combination of extensive surgery, EBRT, and multi-agent chemotherapy in this population...
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IVJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, Box 8224, 4921 Parkview Place, Lower Level, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 59:1027-38. 2004....
Intensity-modulated radiotherapySteven A Leibel
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer J 8:164-76. 2002..The implementation of biologic evaluation of tumor sensitivity, in addition to methods that improve target delineation and dose delivery, represents a new dimension in intensity-modulated radiotherapy research...
The challenging role of radiation therapy for very young children with rhabdomyosarcomaDev R Puri
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 65:1177-84. 2006..Local control may be maximized when EBRT begins <or=18 weeks after initiation of CMT, but further study is warranted. Longer follow-up is required to determine the full extent of late effects...
Symptomatic Chiari type I malformation after radiation therapy in an infant: case reportCaitlin E Hoffman
Department of Neurological Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
Neurosurgery 60:E782; discussion E782. 2007..The authors present an additional case of a 17-month-old girl treated for an isolated, malignant, rhabdoid tumor of the right neck with neoadjuvant chemotherapy, surgical exploration, and radiation therapy...
PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging toolsMichelle L Klem
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Pediatr Hematol Oncol 29:9-14. 2007..Complete staging of rhabdomyosarcoma is critical to deliver appropriate therapy. We evaluated the role of F-fluorodeoxyglucose positron emission tomography (PET) in the staging of patients with rhabdomyosarcoma...
Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumorsDev R Puri
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Pediatr Blood Cancer 50:167-9. 2008..Our limited experience suggests that RT in the setting of CMT and surgery has the potential to prolong survival with acceptable toxicity, but outcomes are inconsistent and further study is necessary...
Radiation-induced salivary gland tumors: a report of 18 cases and a review of the literatureKathryn P Beal
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer J 9:467-71. 2003..This series also suggests an increased risk for developing malignant (versus benign) SGT after radiation exposure...
The management of treatment-related esophageal complications in children and adolescents with cancerDave R Lal
Department of Surgery (Pediatric Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Pediatr Surg 41:495-9. 2006..Strictures usually respond to dilatation, but fistulae require esophageal diversion and secondary reconstruction...
Nasopharyngeal carcinoma: recognizing the radiographic features in childrenHilda E Stambuk
Department of Radiology, Division of Neuroradiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
AJNR Am J Neuroradiol 26:1575-9. 2005..Earlier diagnosis may then direct the patient to timely appropriate therapy when these key radiographic features are present and recognized...
Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumorKaryn A Goodman
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 54:170-6. 2002..Hematologic and gastrointestinal toxicities are expected but manageable with diligent supportive care. The long-term efficacy of this therapy remains disappointing, thus novel approaches are being investigated...
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapyJames B Nachman
Section of Pediatric Hematology Oncology, University of Chicago, Chicago, IL, USA
J Clin Oncol 20:3765-71. 2002....
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network studyEnis Ozyar
Hacettepe University, Oncology Institute, Ankara, Turkey
Radiother Oncol 81:39-46. 2006..This Rare Cancer Network (RCN) study was performed in pediatric nasopharyngeal carcinoma (PNPC) patients to evaluate the optimal dose of radiotherapy and to determine prognostic factors...
Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GrMegan Burke
Children s Hospital Cleveland Clinic, Cleveland, USA
J Clin Oncol 25:4909-13. 2007..For Intergroup Rhabdomyosarcoma Study (IRS) IV patients with group III rhabdomyosarcoma, we assessed whether reported response assessed by anatomic imaging at week 8 predicted FFS...
